Genesis Therapeutics
Founded
2019
2019
Geography
United States of America based
United States of America based
Funding
$4.100 M
$4.100 M
Genesis Therapeutics is provide comprehensive service in all matters of technology transfer.
Their academia-leading research was the initial component of our expanding portfolio of AI technologies. They are combining novel deep neural networks, biophysical simulation, and massively scalable computing infrastructure to achieve industry-leading performance in molecular generation and property prediction.
Technologies
AI Companies (Drug Discovery)R&D Platform
Pipelines
No pipelines published yet
Products
Services
No services posted yet